News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Deals
Quidel Corporation Completes Acquisition of Diagnostic Hybrids, Inc.
February 22, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid diagnostic tests, has completed its previously announced acquisition of Diagnostic Hybrids, Inc. for approximately $130 million in cash.
Twitter
LinkedIn
Facebook
Email
Print
Mergers & acquisitions
MORE ON THIS TOPIC
Job Trends
Biopharma layoffs must double in H2 for 2026 to match 2025 cuts
July 23, 2026
·
4 min read
·
Angela Gabriel
Manufacturing
Repligen strikes $1.5B BioLife buyout to bag cell therapy product pharmas rely on
July 22, 2026
·
2 min read
·
Nick Paul Taylor
IPO
2026 IPO stock tracker: How newly public biotechs are performing
July 22, 2026
·
1 min read
·
Gabrielle Masson
Podcast
Q2 earnings underway, FDA’s CRL kerfuffle, IPOs full speed ahead in H2
July 22, 2026
·
1 min read
·
Jef Akst